Cotellic Approved for Advanced Melanoma

TUESDAY, Nov. 10, 2015 — Cotellic (cobimetinib) in combination with another chemotherapy, vemurafenib (Zelboraf) has been approved by the U.S. Food and Drug Administration to treat melanoma skin cancer that has spread or cannot be surgically…
Source: Topamax